MC-CPA Activators
MC-CPA Activators encompass a range of chemical compounds that function through distinct signaling pathways to augment the activity of MC-CPA. Forskolin, by increasing cyclic AMP (cAMP) levels through adenylyl cyclase activation, facilitates MC-CPA activity via cAMP-dependent protein kinase A (PKA). PKA phosphorylates various proteins that may include regulators of MC-CPA, leading to its enhanced activity. PMA acts by activating protein kinase C (PKC), which is known to phosphorylate substrates that could be part of the MC-CPA activation cascade, thereby amplifying MC-CPA's functional output. Additionally, sphingosine-1-phosphate, through its receptors, can initiate signaling events that culminate in the activation of MC-CPA, while epigallocatechin gallate (EGCG) and the PI3K inhibitors LY294002 and Wortmannin work by inhibiting kinases that otherwise suppress MC-CPA pathways, thereby indirectly boosting its activity.
Further, the modulation of the MAPK signaling pathway by SB203580 and U0126 is thought to favor the activation of MC-CPA by altering the phosphorylation patterns of interacting proteins. A23187, by increasing intracellular calcium, activates calcium-dependent signaling mechanisms that support MC-CPA activity. Genistein, through its inhibition of tyrosine kinases, reducescompetitive phosphorylation, potentially allowing for preferential activation of pathways involving MC-CPA. Staurosporine, despite its broad kinase inhibition profile, may preferentially unblock inhibitory constraints on MC-CPA, while thapsigargin increases intracellular calcium, triggering signaling cascades that lead to MC-CPA activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP enhances MC-CPA activity by protein kinase A (PKA)-mediated phosphorylation of regulatory proteins that interact with MC-CPA, thereby increasing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can lead to phosphorylation of proteins in signaling pathways that converge on MC-CPA activation, resulting in its enhanced functional state. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate engages sphingosine-1-phosphate receptors, which can modulate various signaling cascades, including those that may upregulate MC-CPA activity through downstream effector molecules. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits various protein kinases, which could relieve negative regulatory influences on MC-CPA, thereby indirectly enhancing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter downstream signaling pathways, leading to the activation of MC-CPA by changing the phosphorylation status of proteins that regulate MC-CPA activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that, similar to LY294002, can disrupt signaling pathways to favor the activation state of MC-CPA by affecting the network of proteins that control its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which could shift signaling dynamics to enhance the pathways that activate MC-CPA. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that raises intracellular calcium levels, potentially enhancing MC-CPA activity through calcium-dependent signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, may enhance MC-CPA activity by reducing competitive phosphorylation events, thus favoring pathways that activate MC-CPA. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that can lead to selective enhancement of MC-CPA pathways by inhibiting kinases that negatively regulate MC-CPA. | ||||||